EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

From Antibody Drugs to RNA Interference and Nanotherapy: The Evolution and Integration of Targeted Strategies in Gastric Cancer

Songlin Wang, Yinhong Dong, Lan Ma iD, Jiangfeng Wu, Daoguo Long, Zhao Mei iD, Chuanlin Jiang, Xiaoguang Lyu

International Journal of Nanomedicine · 2026-07 · Volume 21 · 1-15

DOI: 10.2147/ijn.s618409 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026-07. Verfasst von Songlin Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhongxiang People's Hospital, Zhongxiang, People's Republic of China. Hauptthemen laut MEDLINE: Stomach Neoplasms, RNA Interference. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsRNA InterferenceHumansNanoparticlesRNA, Small InterferingAnimalsTumor MicroenvironmentNanomedicineAntineoplastic AgentsDrug Delivery SystemsMolecular Targeted TherapyDrug CarriersNanoparticle Drug Delivery System

Stichwörter der Autor:innen

RNA interferencegastric cancernanoparticlesshRNAsiRNAtarget therapy

Substanzen

RNA, Small InterferingAntineoplastic AgentsDrug CarriersNanoparticle Drug Delivery System

Autor:innen und Institutionen

  • Zhongxiang People's Hospital, Zhongxiang, People's Republic of China.
  • Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People's Republic of China.
  • College of Basic Medical Science, China Three Gorges University, Yichang, People's Republic of China.
  • Institute of Organ Fibrosis and Targeted Drug Delivery, China Three Gorges University, Yichang, People's Republic of China.
  • Department of Pharmacy, The First College of Clinical Medical Science, China Three Gorges University, Yichang, People's Republic of China.
  • Department of Pharmacy, Yichang Central People's Hospital, Yichang, People's Republic of China.

ORCID-Profile: Lan Ma, Zhao Mei

Zitieren

APA

Wang, S., Dong, Y., Ma, L., Wu, J., Long, D., Mei, Z., Jiang, C., & Lyu, X. (2026). From Antibody Drugs to RNA Interference and Nanotherapy: The Evolution and Integration of Targeted Strategies in Gastric Cancer. International Journal of Nanomedicine, Volume 21, 1-15. https://doi.org/10.2147/ijn.s618409

Vancouver

Wang S, Dong Y, Ma L, Wu J, Long D, Mei Z, et al. From Antibody Drugs to RNA Interference and Nanotherapy: The Evolution and Integration of Targeted Strategies in Gastric Cancer. International Journal of Nanomedicine. 2026;Volume 21:1-15. doi:10.2147/ijn.s618409

BibTeX
@article{Wang2026,
  author = {Wang, Songlin and Dong, Yinhong and Ma, Lan and Wu, Jiangfeng and Long, Daoguo and Mei, Zhao and Jiang, Chuanlin and Lyu, Xiaoguang},
  title = {From Antibody Drugs to RNA Interference and Nanotherapy: The Evolution and Integration of Targeted Strategies in Gastric Cancer},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  volume = {Volume 21},
  pages = {1--15},
  doi = {10.2147/ijn.s618409}
}
Kostenlos starten →